Researchers find a way to create a renewable supply of cancer-fighting T cells

Researchers at the University of California, Los Angeles have made a major advance in the battle against cancer by showing that it’s possible to create mature T cells with important cancer-killing receptors from pluripotent stem cells.

This was achieved by using structures called artificial thymic organoids, which mimic the environment of the thymus, referring to the organ in which T cells develop from blood stem cells.

“Using living T cells to kill cancer cells is one of the most exciting areas of cancer treatment,” Christopher Seet, a clinical instructor in the David Geffen School of Medicine at UCLA, told Digital Trends. “The idea here would be to use self-renewing pluripotent stem cells to make unlimited numbers of T cells in the lab, which could be used directly in patients. With certain tweaks, pluripotent stem cells can be genetically engineered to make T cells that would work in any individual. [This] could make T cell immunotherapies cheaper and more widely available. Currently, T cell therapies use a patient’s own T cells and it takes time and great expense to genetically engineer these T cells and give them back to the patient. In some cases, patients may not qualify if they’re too sick, don’t have enough T cells, or the cell quality is not good enough. Faster and cheaper ‘off-the-shelf’ approaches to T cell therapies are badly needed to bring these treatments to more patients.”

This “off-the-shelf” approach could ultimately work to make T cell therapies more accessible, more affordable, and — perhaps most importantly — more effective. There’s still a way to go until this work rolls out to patients, but it is extremely promising.

“Our next goal is to engineer the pluripotent stem cells to make T cells that are suited for treating any individual,” Seet continued. “To do this we need to make sure that the T cells we make are not rejected by a patient’s immune system, and also specifically attack a patient’s tumor cells and not the rest of their body. We can achieve this by engineering these traits in the stem cells, and indeed our goal is to make T cells that not only can be given to any individual, but may function better than T cells from the blood.”

A paper describing the work was recently published in the journal Cell Stem Cell. Other researchers on the work included Gay Crooks and Amélie Montel-Hagen.

Emerging Tech

Global Good wants to rid the world of deadly diseases with lasers and A.I.

Global Good, a collaboration between Intellectual Ventures and Bill Gates, aims to eradicate diseases that kill children in developing nations. It tackles difficult problems with high-tech prototypes.
Health & Fitness

Immune cell discovery takes us one step closer to a universal flu vaccine

A group of international researchers have made a discovery which could take us one step closer to the universal, one-shot flu vaccine that people around the world have been dreaming of.
Emerging Tech

No faking! Doctors can now objectively measure how much pain you’re in

Researchers at Indiana University School of Medicine have discovered the blood biomarkers that can objectively reveal just how much pain a patient is in. Here's why that's so important.
Emerging Tech

Statistician raises red flag about reliability of machine learning techniques

Machine learning is everywhere in science and technology. But how reliable are these techniques really? A statistician argues that questions of accuracy and reproducibility of machine learning have not been fully addressed.
Smart Home

No strings attached: This levitating lamp uses science to defy gravity

Now on Kickstarter, the Levia lamp is a cool industrial-looking lamp which boasts a levitating bulb. Looking for a table light that will dazzle visitors? You've come to the right place.
Emerging Tech

The Great White Shark’s genome has been decoded, and it could help us end cancer

In a significant step for marine and genetic science, researchers have decoded the genome of the great white shark. The genetic code revealed a wealth of insight into what makes these creatures so successful from an evolutionary standpoint.
Emerging Tech

We tried a $500 electronic dab rig, and now we can’t go back to normal vaporizers

Induction heating is the future of cannabis vaporizers. Loto Labs wowed us with what likely is the best concentrate vaporizer on the market today. With a $500 price tag, it's expensive, but it should definitely be your next dab rig.
Emerging Tech

‘Guerrilla rainstorm’ warning system aims to prevent soakings, or worse

Japanese researchers have created a "guerrilla rainstorm" early-warning system aimed at preventing severe soakings, or worse. The team hopes to launch the system before the 2020 Tokyo Olympics.
Mobile

Barbie’s Corvette ain’t got nothing on Sphero’s fully programmable robot car

Sphero is known for devices like the Sphero Bolt and BB-8 Star Wars toy, but now the company is back with another addition to its lineup -- the Sphero RVR. The RVR is a fully programmable robot car that can be expanding with different…
Emerging Tech

Japanese spacecraft will collect a sample from asteroid Ryugu by shooting at it

The Japanese spacecraft Hayabusa 2 will soon touch down on the asteroid Ryugu, where it will collect a sample by shooting a bullet into the soil. The sample will be returned to Earth in 2020 to learn about the formation of asteroids.
Emerging Tech

Hong Kong’s vision for a smart prison is a full-blown Orwellian nightmare

Hong Kong wants to bring prisons up to date by introducing new location-tracking wristbands for inmates, and a robot arm whose job is to comb through poop on the lookout for contraband.
Emerging Tech

SeaBubbles’ new electric hydrofoil boat is the aquatic equivalent of a Tesla

What do you get if you combine a Tesla, a flying car, and a sleek boat? Probably something a bit like SeaBubbles, the French "flying" boat startup which offers a fresh spin on the hydrofoil.
Emerging Tech

Israel will launch world’s first privately funded moon mission tomorrow

This week will see the world's first privately funded lunar mission launch. Israel's first mission to the moon will be launched aboard SpaceX's Falcon 9 rocket on Thursday, February 21.
Emerging Tech

FDA warns about the dangers of anti-aging blood transfusions

It turns out injecting old people with blood from healthy youngsters may not be the answer to health rejuvenation. That’s according to the FDA, which says such claims are dangerous junk science.